查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球臨床診斷市場
市場調查報告書
商品編碼
1289007

全球臨床診斷市場

Clinical Diagnostics: Global Markets
出版日期: | 出版商: BCC Research | 英文 111 Pages | 訂單完成後即時交付

價格

全球臨床診斷市場規模將從 2022 年的 678 億美元增長到 2023 年的 731 億美元，在 2023 年至 2028 年的預測期內復合年增長率為 7.2%，預計增長到1034億美元。

脂質板市場預計將從 2023 年的 281 億美元增長到 2028 年的 403 億美元，複合年增長率為 7.5%。 預計傳染病檢測行業將從 2023 年的 195 億美元增長到 2028 年的 284 億美元，複合年增長率為 7.8%。

在這份報告中，我們研究了全球臨床診斷市場，市場和技術背景，市場影響因素分析，市場規模的轉變和預測，各細分市場和地區的詳細分析，新興技術分析，總結了具有競爭力的環境，主要公司概況等。

內容

第一章介紹

第 2 章要點摘要

第三章市場與技術背景

  • 概覽
  • 質量控制
  • 質量保證
  • 周轉時間
  • 臨床相關性
  • 精確可靠
  • 患者安全
    • 癌症篩查
    • 新生兒篩查
    • 傳染病篩查
    • 篩查心血管疾病
  • 篩選類型
  • 篩選測試
  • 篩選指南
  • 篩查的好處
  • 篩選限制
  • 基因檢測
  • 藥物基因組學
  • 生物標誌物測試
  • 蛋白質組學
  • 代謝組學

第 4 章按測試類型劃分的臨床診斷市場細分

  • 脂質組
  • 傳染病檢測
  • 全血細胞計數
  • 代謝組測試
  • 異常的代謝組結果
  • 其他測試

第 5 章按產品類型劃分的臨床診斷市場細分

  • 檢測試劑盒
  • 設備
  • 試劑
  • 軟件服務

第 6 章按應用劃分的臨床診斷市場細分

  • 感染
  • 癌症
    • 癌症類型
    • 致癌原因
    • 癌症症狀
    • 癌症診斷
    • 癌症治療
  • 心血管疾病

第 7 章臨床診斷市場細分：按最終用戶

  • 診斷實驗室
  • 醫院和診所
  • 其他

第 8 章臨床診斷市場細分：按地區

  • 全球市場規模和預測
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第 9 章市場動態

  • 市場驅動因素
  • 市場挑戰

第 10 章新興技術

  • 分子診斷
  • 下一代測序 (NGS)
  • 即時檢測
  • 人工智能
  • 其他

第11章競爭格局

第12章公司簡介

  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX S.A.
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN N.V.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
Product Code: BIO243A

Highlights:

The global market for clinical diagnostics reached $67.8 billion in 2022. The market is estimated to grow from $73.1 billion in 2023 to reach $103.4 billion by 2028, at a compound annual growth rate (CAGR) of 7.2% from 2023 through 2028.

The lipid panel segment of the global clinical diagnostics market is estimated to grow from $28.1 billion in 2023 to reach $40.3 billion by 2028, at a CAGR of 7.5% from 2023 through 2028.

The infectious disease testing segment of the global clinical diagnostics market is estimated to grow from $19.5 billion in 2023 to reach $28.4 billion by 2028, at a CAGR of 7.8% from 2023 through 2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for clinical diagnostics, both quantitative and qualitative data, to help executives develop corporate growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics.

An in-depth market analysis includes historical data and market projections on sales by type of test, product type, application, end user and region. It describes the different types of clinical diagnostic tests and their current and historical market revenues. This report also categorizes the global clinical diagnostic market based on four geographic regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW).

For a more in-depth understanding of the market, the report provides profiles of leading companies and their respective market shares.

Report Includes:

  • 22 data tables
  • An up-to-date overview and analysis of the global clinical diagnostics market
  • Analyses of the global market trends, with historic market revenue data (sales figures) from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion of the major growth drivers, opportunities and challenges, technology updates, and the impact of macroeconomic variables influencing the market for clinical diagnostics as a basis for projecting demand in the next few years (2023-2028)
  • Estimation of the actual market size and revenue forecast for global clinical diagnostics market, and corresponding market share analysis based on the type of test, product and service, application, end user, and region
  • In-depth information (facts and figures) concerning the major market dynamics, screening tools and techniques, regulatory developments, new and emerging technologies, and current competitive landscape of the clinical diagnostic market
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Siemens Healthineers, Roche Diagnostics, Qiagen and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Improved Patient Outcomes
  • 1.2 Improved Public Health
  • 1.3 Reduced Healthcare Costs
  • 1.4 Study Goals and Objectives
  • 1.5 Reasons for Doing the Study
  • 1.6 Scope of Report
  • 1.7 Methodology and Information Sources
  • 1.8 Geographic Breakdown
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • 3.1 Overview
  • 3.2 Quality Control
  • 3.3 Quality Assurance
  • 3.4 Turnaround Time
  • 3.5 Clinical Correlation
  • 3.6 Accuracy and Reliability
  • 3.7 Patient Safety
    • 3.7.1 Cancer Screening
    • 3.7.2 Newborn Screening
    • 3.7.3 Infectious Disease Screening
    • 3.7.4 Cardiovascular Disease Screening
  • 3.8 Types of Screening
  • 3.9 Screening Tests
  • 3.10 Screening Guidelines
  • 3.11 Benefits of Screening
  • 3.12 Limitations of Screening
  • 3.13 Genetic Testing
  • 3.14 Pharmacogenomics
  • 3.15 Biomarker Testing
  • 3.16 Proteomics
  • 3.17 Metabolomics

Chapter 4 Clinical Diagnostics Market Breakdown by Type of Test

  • 4.1 Introduction
    • 4.1.1 Lipid Panels
    • 4.1.2 Infectious Disease Testing
    • 4.1.3 Complete Blood Count
    • 4.1.4 Metabolic Panel Testing
    • 4.1.5 Abnormal Metabolic Panel Results
    • 4.1.6 Other Tests

Chapter 5 Clinical Diagnostics Market Breakdown by Product Type

  • 5.1 Introduction
  • 5.2 Assays and Kits
    • 5.2.1 Types of Assays and Kits in Clinical Diagnostics
  • 5.3 Instruments
    • 5.3.1 Types of Instruments
  • 5.4 Reagents
    • 5.4.1 Types of Reagents
  • 5.5 Software and Services
    • 5.5.1 Data Management

Chapter 6 Clinical Diagnostics Market Breakdown by Application

  • 6.1 Introduction
  • 6.2 Infectious Diseases
  • 6.3 Cancer
    • 6.3.1 Types of Cancer
    • 6.3.2 Causes of Cancer
    • 6.3.3 Symptoms of Cancer
    • 6.3.4 Diagnosis of Cancer
    • 6.3.5 Treatment of Cancer
  • 6.4 Cardiovascular Disease

Chapter 7 Clinical Diagnostics Market Breakdown by End User

  • 7.1 Introduction
  • 7.2 Diagnostic Laboratories
  • 7.3 Hospitals and Clinics
  • 7.4 Other End Users

Chapter 8 Clinical Diagnostics Market Breakdown by Region

  • 8.1 Introduction
  • 8.2 Global Market Size and Forecast
  • 8.3 North America
    • 8.3.1 United States
    • 8.3.2 Canada
  • 8.4 Europe
    • 8.4.1 Germany
    • 8.4.2 United Kingdom
  • 8.5 Asia-Pacific
  • 8.6 Rest of the World

Chapter 9 Market Dynamics

  • 9.1 Market Drivers
    • 9.1.1 Advances in Technology
    • 9.1.2 Increasing Prevalence of Chronic and Infectious Diseases
    • 9.1.3 Autoimmune Disorders
    • 9.1.4 Aging Population
    • 9.1.5 Rising Healthcare Expenditures
    • 9.1.6 Point-of-Care Testing
    • 9.1.7 Personalized Medicine
  • 9.2 Market Challenges
    • 9.2.1 Stringent Regulatory Scenario
    • 9.2.2 Reimbursement Challenges
    • 9.2.3 Increasing Market Competition

Chapter 10 Emerging Technologies

  • 10.1 Molecular Diagnostics
  • 10.2 Next-Generation Sequencing (NGS)
  • 10.3 Point-of-Care Testing
  • 10.4 Artificial Intelligence (AI)
  • 10.5 Other Emerging Techniques

Chapter 11 Competitive Landscape

  • 11.1 Overview

Chapter 12 Company Profiles

  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX S.A.
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN N.V.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.

List of Tables

  • Summary Table A : Global Market for Clinical Diagnostics, by Type of Test, Through 2028
  • Summary Table B : Global Market for Clinical Diagnostics, by Region, Through 2028
  • Table 1 : Global Market for Clinical Diagnostics, by Type of Test, Through 2028
  • Table 2 : Global Market for Clinical Diagnostics, by Product Type, Through 2028
  • Table 3 : Global Market for Clinical Diagnostics, by Application, Through 2028
  • Table 4 : Global Market for Clinical Diagnostics, by End User, Through 2028
  • Table 5 : Global Market for Clinical Diagnostics, by Region, Through 2028
  • Table 6 : North American Market for Clinical Diagnostics, by Country, Through 2028
  • Table 7 : European Market for Clinical Diagnostics, by Country, Through 2028
  • Table 8 : Asia-Pacific Market for Clinical Diagnostics, by Country, Through 2028
  • Table 9 : RoW Market for Clinical Diagnostics, by Sub-region, Through 2028
  • Table 10 : Abbott Diagnostics: Product Portfolio
  • Table 11 : Becton, Dickinson and Co.: Company Financials, 2022
  • Table 12 : Becton, Dickinson and Co.: Product Portfolio
  • Table 13 : bioMerieux SA: Product Portfolio
  • Table 14 : Bio-Rad Laboratories Inc.: Company Financials, 2022
  • Table 15 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 16 : Danaher Corp.: Company Financials, 2022
  • Table 17 : Danaher Corp.: Product Portfolio
  • Table 18 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 19 : Qiagen: Product Portfolio
  • Table 20 : Siemens Healthineers AG: Product Portfolio

List of Figures

  • Summary Figure A : Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
  • Summary Figure B : Global Market for Clinical Diagnostics, by Region, 2020-2028
  • Figure 1 : Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
  • Figure 2 : Global Market for Clinical Diagnostics, by Product Type, 2020-2028
  • Figure 3 : Global Market for Clinical Diagnostics, by Application, 2020-2028
  • Figure 4 : Global Market for Clinical Diagnostics, by End User, 2020-2028
  • Figure 5 : Global Market for Clinical Diagnostics, by Region, 2020-2028
  • Figure 6 : North American Market for Clinical Diagnostics, by Country, 2020-2028
  • Figure 7 : European Market for Clinical Diagnostics, by Country, 2020-2028
  • Figure 8 : Asia-Pacific Market for Clinical Diagnostics, by Country, 2020-2028
  • Figure 9 : RoW Market for Clinical Diagnostics, by Sub-region, 2020-2028
  • Figure 10 : Projected Worldwide Rate of Incidence of Diabetes in Patients Aged 20 to 79 Years, 2010 and 2030
  • Figure 11 : Abbott Laboratories: Diagnostics Division, Net Revenue, 2020-2022
  • Figure 12 : Abbott Diagnostics: Market Share, by Business Segment, 2022
  • Figure 13 : Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2022
  • Figure 14 : Becton, Dickinson and Co.: Revenue Share, by Region, 2022
  • Figure 15 : bioMerieux SA: Net Annual Revenue, 2020-2022
  • Figure 16 : bioMerieux SA: Market Share, by Application, 2022
  • Figure 17 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Segment, 2022
  • Figure 18 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
  • Figure 19 : Danaher Corp.: Revenue Share, by Business Segment, 2022
  • Figure 20 : Danaher Corp.: Revenue Share, by Region, 2022
  • Figure 21 : F. Hoffmann-La Roche Ltd.: Diagnostics Division, Net Revenue, 2020-2022
  • Figure 22 : F. Hoffmann-La Roche Ltd.: Diagnostics Division, Market Share, by Customer Area, 2022
  • Figure 23 : Qiagen: Net Revenue, 2020-2022
  • Figure 24 : Qiagen: Market Share, by Product Type, 2022
  • Figure 25 : Siemens Healthineers AG: Net Revenue, 2020-2022
  • Figure 26 : Siemens Healthineers AG: Market Share, by Business Segment, 2022
  • Figure 27 : Thermo Fisher Scientific Inc.: Annual Revenue, 2020-2022
  • Figure 28 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022